Website stats and analysis

INDICATION AND IMPORTANT SAFETY INFORMATIONILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).IMPORTANT SAFETY INFORMATION What is the most important information I should know about ILUMYA?Do not use ILUMYA if you have had a severe...

2.48 Rating by Usitestat

ilumya.com was registered 1 decade 2 months ago. It has a alexa rank of #1,338,668 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, ilumya.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 655
Daily Pageviews: 1,310

Estimated Valuation

Income Per Day: $ 4.00
Estimated Worth: $ 960.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 1,338,668
PageSpeed Score: 69 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

54.192.94.112

Hosted Country:

Germany DE

Location Latitude:

50.1155

Location Longitude:

8.68417

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For ilumya.com

ILUMYA™ (tildrakizumab-asmn) | Plaque Psoriasis Treatment

- https://www.ilumya.com/

IMPORTANT SAFETY INFORMATION. ILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills...


Psoriasis Medication | ILUMYA™ (tildrakizumab-asmn) HCP

- https://www.ilumyapro.com/

INDICATION AND IMPORTANT SAFETY INFORMATION. ILUMYA ™ (tildrakizumab-asmn) is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates...


ILUMYA™ US Prescribing Information

- https://www.ilumya.com/pdfs/Sun_Pharma_ILUMYA_US_Prescribing_Information.pdf

ILUMYA safely and effectively. See full prescribing information for ILUMYA. ILUMYA™ (tildrakizumab-asmn) injection, for subcutaneous use Initial U.S. Approval: 2018...


Ilumya : Side Effects, Dosage & Uses - Drugs.com

- https://www.drugs.com/ilumya.html

Mar 01, 2019 · Ilumya was FDA approved in 2018 and Skyrizi was FDA approved in 2019. Ilyumya is a brand name for tildrakizumab and Skyrizi is a brand name for risankizumab The...


X X X X - ilumyaform.com

- http://ilumyaform.com/

• ILUMYA SUPPORT™ may contact me for additional information relating to the Program, including but not limited to via email, fax, telephone, and text. I understand that the...


Safety Profile | ILUMYA™ (tildrakizumab-asmn) HCP

- https://www.ilumyapro.com/safety-profile/

ILUMYA™ is the only IL-23 inhibitor with incidence of tinea occurring in <1% of patients in clinical trials 1-3 Upper respiratory infections Injection site reactions Diarrhea A...


ILUMYA™ (tildrakizumab-asmn) - Home | Facebook

- https://www.facebook.com/ilumya

ILUMYA is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for...


Ilumya (Tildrakizumab-asmn Injection, for Subcutaneous Use ...

- https://www.rxlist.com/ilumya-drug.htm

Apr 04, 2018 · ILUMYA is a clear to slightly opalescent, colorless to slightly yellow solution. ILUMYA (tildrakizumab-asmn) Injection is a sterile, preservative-free, clear to...


Ilumya: Dosage, side effects, uses, and more

- https://www.medicalnewstoday.com/articles/326247

Jan 27, 2019 · Ilumya (tildrakizumab-asmn) is a brand-name prescription medication that's used to treat moderate to severe plaque psoriasis. It's given as an injection by …


Drug Trials Snapshots: ILUMYA | FDA

- https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-ilumya

ILUMYA is a drug for treatment of moderate to severe plaque psoriasis, in adults, who may benefit from taking injections or pills (systemic therapy) or treatment using...


ILUMYA Prescription Price Comparison | Compare Drug Prices

- https://www.wellrx.com/prescriptions/ilumya/

ILUMYA Savings, Coupons and Information. | TILDRAKIZUMAB (til drak iz u mab) is a monoclonal antibody. It is used to treat psoriasis.


Ilumya Subcutaneous : Uses, Side Effects, Interactions ...

- https://www.webmd.com/drugs/2/drug-175874/ilumya-subcutaneous/details

Ilumya 100 Mg/Ml Subcutaneous Syringe Monoclonal Antibody, Interleukin 23 Antagonists. GENERIC NAME(S): Tildrakizumab-Asmn. OTHER NAME(S): Ilumya Syringe


Ilumya - PURE Infusion Suites

- https://pureinfusionsuites.com/treatments/ilumya/

Ilumya is used to treat moderate to severe plaque psoriasis. Tildrakizumab-asmn belongs to a class of drugs known as monoclonal antibodies.It works by blocking a certain natural...


Authorization Request Forms | Providers | Excellus ...

- https://provider.excellusbcbs.com/authorizations/medical/prescriptions

Ilumya Open a PDF: Drug Prior Authorization Request Forms Inborn Errors of Metabolism & Rare Genetic Diseases (Health Professional Administration/Medical Benefit) - Aldurazyme...


Reference ID: 4237577

- https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf

ILUMYA group (23%), the difference in frequency of infections between the ILUMYA group and the placebo group was less than 1% during the placebo-controlled period. However,...


Sun Pharma Announces U.S. FDA Approval of ILUMYA ...

- https://www.prnewswire.com/news-releases/sun-pharma-announces-us-fda-approval-of-ilumya-tildrakizumab-asmn-for-the-treatment-of-moderate-to-severe-plaque-psoriasis-300617454.html

Mar 21, 2018 · ILUMYA selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL-23 receptor leading to inhibition of the release of pro-inflammatory...


Sun Pharma declares five-year positive results for ILUMYA ...

- https://www.expresspharma.in/latest-updates/sun-pharma-declares-five-year-positive-results-for-ilumya-tildrakizumab-asmn/

Nov 01, 2020 · ILUMYA 100 mg is approved in the US, Japan and Australia, and 200 mg is additionally approved under the brand name ILUMETRI™ in Europe. In patients who were...


Side Effects of Ilumya (Tildrakizumab-asmn Injection, for ...

- https://www.rxlist.com/ilumya-side-effects-drug-center.htm

Apr 04, 2018 · Ilumya (tildrakizumab-asmn) injection is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are...

Page Resources Breakdown

Homepage Links Analysis

ILUMYA™ (tildrakizumab-asmn) | Plaque Psoriasis Treatment
Learn more about prescribing information, convenient dosing, and saftey profile for ILUMYA, a treatment for moderate to severe plaque psoriasis.

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 7
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: 1 Total Images: 8
Google Adsense: Not Applicable Google Analytics: Not Applicable

Mobile Friendly Check


Mobile Friendly : Unknown
Score : Unknown

No data to show.

Websites Hosted on Same IP (i.e. 54.192.94.112)

Otter Volleyball Camps

- ottervolleyballcamps.com

Otter Volleyball Camps are held at the Otter Sports Center on the campus of California State University, Monterey Bay. Otter Volleyball Camps are led by the California State...

  13,853,873   $ 8.95

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Content-Type: text/html; charset=UTF-8
Content-Length: 6684
Connection: keep-alive
Accept-Ranges: bytes
Content-Encoding: gzip
Date: Sat, 25 May 2019 17:06:05 GMT
Last-Modified: Mon, 01 Apr 2019 12:21:20 GMT
Server: Apache
Age: 26436
Vary: Accept-Encoding
X-Cache: Hit from cloudfront
Via: 1.1 a2289d8b15b881db1c42086062568883.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: FRA2
X-Amz-Cf-Id: i8WCfNYW7JVB_lSD4-PV5uE1E_dmUNEXdIQqF2e434oshEF5VrE8EA==

Domain Information

Domain Registrar: GoDaddy.com, LLC
Registration Date: 2014-02-26 1 decade 2 months 2 weeks ago
Last Modified: 2019-03-01 5 years 2 months 2 weeks ago

Domain Nameserver Information

Host IP Address Country
ns-1137.awsdns-14.org 205.251.196.113 United States United States
ns-1839.awsdns-37.co.uk 205.251.199.47 United States United States
ns-672.awsdns-20.net 205.251.194.160 United States United States
ns-75.awsdns-09.com 205.251.192.75 United States United States

DNS Record Analysis

Host Type TTL Extra
ilumya.com A 46 IP: 54.192.94.112
ilumya.com A 46 IP: 54.192.94.62
ilumya.com A 46 IP: 54.192.94.76
ilumya.com A 46 IP: 54.192.94.68
ilumya.com NS 172800 Target: ns-1137.awsdns-14.org
ilumya.com NS 172800 Target: ns-1839.awsdns-37.co.uk
ilumya.com NS 172800 Target: ns-672.awsdns-20.net
ilumya.com NS 172800 Target: ns-75.awsdns-09.com
ilumya.com SOA 900 MNAME: ns-75.awsdns-09.com
RNAME: awsdns-hostmaster.amazon.com
Serial: 1
Refresh: 7200
Retry: 900
Expire: 1209600

Alexa Traffic Rank

Alexa Search Engine Traffic

Full WHOIS Lookup

Domain Name: ILUMYA.COM
Registry Domain ID:
1848271026_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2019-02-28T19:10:40Z
Creation Date:
2014-02-26T14:19:52Z
Registry Expiry Date:
2020-02-26T14:19:52Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS-1137.AWSDNS-14.ORG
Name Server:
NS-1839.AWSDNS-37.CO.UK
Name Server: NS-672.AWSDNS-20.NET
Name
Server: NS-75.AWSDNS-09.COM
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2019-07-06T12:40:44Z

Similarly Ranked Websites

Бесплатные торрент игры — игры RePack скачать торрент

- repack-games.net

Наш сайт предлагает тебе скачать Repack игры для PC через торрент гарантированного качества от лучших релиз групп

1,338,671   $ 960.00

Cislo & Thomas LLP, Patent Copyright Trademark Attorneys

- cisloandthomas.com

Intellectual Property, Patent, Trademark, Copyright Litigation in West Los Angeles/Santa Monica, Westlake Village, Santa Barbara, Pasadena, Torrance & San Diego

1,338,678   $ 960.00


Vitalmed - Serviços de Emergências Médica -

- vitalmed.com.br

1,338,680   $ 960.00

ThaiSmile.jp(タイ国情報、タイ語とフォトギャラリー)- タイスマイル - Thai Information, Thai...

- thaismile.jp

English / Japanese. タイ王国に関するページです。タイの基本情報からタイ語(音声付き)やフォトギャラリー、壁紙など。 The website about Thailand. General information, Thai language, Thai history, Photo gallery, and Wallpapers....

1,338,682   $ 960.00